ReviewDrug development research2025
Exploring Artificial Intelligence's Potential to Enhance Conventional Anticancer Drug Development.
Sorin-Ștefan Bobolea et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it